Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2)
Publication
, Conference
Richardson, PG; Alsina, M; Weber, DM; Coutre, SE; Lonial, S; Gasparetto, C; Warsi, G; Ondovik, M; Mukhopadhyay, S; Snodgrass, S; Schlossman, R
Published in: BLOOD
November 18, 2011
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
370 / 371
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Richardson, P. G., Alsina, M., Weber, D. M., Coutre, S. E., Lonial, S., Gasparetto, C., … Schlossman, R. (2011). Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2). In BLOOD (Vol. 118, pp. 370–371). San Diego, CA: AMER SOC HEMATOLOGY.
Richardson, Paul G., Melissa Alsina, Donna M. Weber, Steven E. Coutre, Sagar Lonial, Cristina Gasparetto, Ghulam Warsi, et al. “Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2).” In BLOOD, 118:370–71. AMER SOC HEMATOLOGY, 2011.
Richardson PG, Alsina M, Weber DM, Coutre SE, Lonial S, Gasparetto C, et al. Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2). In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 370–1.
Richardson, Paul G., et al. “Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2).” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 370–71.
Richardson PG, Alsina M, Weber DM, Coutre SE, Lonial S, Gasparetto C, Warsi G, Ondovik M, Mukhopadhyay S, Snodgrass S, Schlossman R. Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2). BLOOD. AMER SOC HEMATOLOGY; 2011. p. 370–371.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
370 / 371
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology